Legal Aspects of Biotechnology Innovation Essay

Open, View, and/or
Download this Document

Total Length: 1189 words ( 4 double-spaced pages)

Total Sources: 1

Page 1 of 4

The idea is to examine a variety of sources, to determine the full effects that various dosages will have on a number of individuals. (Campbell, 2007, pp. 2018 -- 2024)

Number of Claims

Independent Claims

1. The method of independent claim one wherein is: that dosages between 75 mg and 81 mg, will not have any kind of significant long-term impact on the individual.

2. The method of independent claim two wherein is: that 50% of respondents, who were given low dosages of aspirin, show little to no positive improvements in their condition.

3. The method of independent claim three wherein is: that women were more than likely, to see the positive effects from taking aspirin in comparison with men.

4. The method of the independent claim number four: is that the long-term effects of taking aspirin; will have a greater impact upon reducing the underlying levels of platelet formation in women. (Campbell, 2007, pp. 2018 -- 2024)

Dependent Claims

1. The method of claim number one wherein is: the use of aspirin therapy was first introduced by Paul Gibson in 1948. Yet, it was not until 30 years later that the benefits of taking aspirin were fully realized.

2. The method of claim number two wherein is: that LL Craven would build off of the ideas of Gibson in 1953, confirming some of the effects of using aspirin to treat coronary artery disease.

3. The method of claim number three wherein is: that there have been various studies all confirming the effectiveness of taking lower dosages of aspirin (with most recommending usage between 30mg and 130 mg).

4. The method of claim number four wherein: is that researchers found those who take dosages of 30 mg to 283 mg, saw a dramatic improvement in the underlying levels of health after a stroke.

Stuck Writing Your "Legal Aspects of Biotechnology Innovation" Essay?

View All Our Example Legal Aspects of Biotechnology Innovation Essay

Have A Custom Example Essay Written



5. The method of claim number five wherein: is that other studies have found similar effects as lower dosages, when patients are given greater amounts of aspirin (up to 1500 mg).

6. The method of claim number six wherein: is that 60 different research studies found no effect between changes in the underlying dosage.

7. The method of claim number seven wherein is: that aspirin taking through chewing or other means will help to increase the absorption rate.

8. The method of claim number eight wherein is: a large number of studies have provided, mixed results on the underlying effects of taking aspirin in treating coronary artery disease.

9. The method of claim number nine wherein is: that 60% of doctors believe that lower dosages of aspirin are more effective.

10. The method of claim number ten wherein is: that large clinical trials have not been able to show the effectiveness of using higher levels of dosage.

11. The method of claim number eleven wherein is: that those who have taken lower dosages after a stroke, will have a 14.7% chance of having a second one 2.6 years later, compared with 15.7% for higher dosages.

12. The method of claim number twelve wherein is: that 11 different studies showed similar rates of recurring stoke and heart attack (regardless of the dosage).

13. The method of claim number thirteen wherein is: that patients who received a dosage of 100 mg were able to see the best results from aspirin therapy.

14. The method of claim number fourteen wherein is: that aspirin taken without being chewed or by drinking water, can slow.....

Show More ⇣

     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"Legal Aspects Of Biotechnology Innovation" (2010, September 30) Retrieved May 22, 2025, from
https://www.aceyourpaper.com/essays/legal-aspects-biotechnology-innovation-8142

Latest MLA Format (8th edition)

Copy Reference
"Legal Aspects Of Biotechnology Innovation" 30 September 2010. Web.22 May. 2025. <
https://www.aceyourpaper.com/essays/legal-aspects-biotechnology-innovation-8142>

Latest Chicago Format (16th edition)

Copy Reference
"Legal Aspects Of Biotechnology Innovation", 30 September 2010, Accessed.22 May. 2025,
https://www.aceyourpaper.com/essays/legal-aspects-biotechnology-innovation-8142
   

Open, View, and/or
Download this Document
order custom essay example